Britannia Life Sciences Inc. Announces First Quarter Results
Britannia Life Sciences Inc. Announces First Quarter Results
Toronto, Ontario--(Newsfile Corp. - August 29, 2023) - Britannia Life Sciences Inc. (CSE: BLAB) (FSE: L020) ("Britannia" or the "Company") is pleased to provide its unaudited financial results for the three months ended June 30, 2023. These filings and additional information regarding Britannia are available for review on SEDAR at . All amounts are Canadian dollars unless otherwise stated.
安大略省多倫多-(Newsfile Corp.-2023年8月29日)-Britannia Life Science Inc.(CSE：BLAB)(FSE：L020)(“不列顛“或”公司“)很高興提供截至2023年6月30日的三個月的未經審計的財務業績。這些檔案和有關不列顛的其他資訊可在SEDAR上查閱。除非另有說明，所有金額都是加元。
Q1 2024 Highlights:
2024年第一季度亮點：
- Revenue for the three months ended June 30, 2023, was $1.96m (2022: $1.51m)
- 截至2023年6月30日的三個月收入為196萬美元(2022年：1510萬美元)
- During the three months ended June 30, 2023, the Company generated gross profit of $1.47m (2022: $1.1m)
- 在截至2023年6月30日的三個月中，該公司創造了147萬美元的毛利潤(2022年：110萬美元)
- The Company reports Adjusted EBITDA of $778k for the quarter ended June 30, 2023 (2022: $626k). Cash flows from operating activities for the three-month period ended June 30, 2023, was $615k (2022: $14k).
- 該公司報告截至2023年6月30日的季度調整後EBITDA為77.8萬美元(2022年：62.6萬美元)。截至2023年6月30日的三個月期間，來自經營活動的現金流為61.5萬美元(2022年：1.4萬美元)。
As previously announced, significant corporate developments during the quarter include:
正如之前宣佈的那樣，該季度的重大公司發展包括：
On April 7, 2023, 9,992,340 convertible debenture warrants, that were classified as liabilities, expired unexercised. On May 12, 2023, 10,281,940 share purchase warrants expired unexercised.
On June 5, 2023, Britannia Mining Solutions Inc. ("BMS"), a partially owned subsidiary of Britannia, acquired a 100% interest in Paragon Geochemical Laboratories Inc. ("Paragon"). Paragon operates an industry-leading, fully accredited geochemical laboratory in Nevada, providing mineral assays and geochemical analyses to the mining industry. The acquisition was financed, in part, through a new debt facility provided by a Canadian private lender.
On June 6, 2023, Britannia acquired an initial 51% interest in Cosmetic Lab Ltd ("CosLab"). Based in southern England, CosLab is a leading independent regulatory partner and manufacturer of high-quality cosmetic products for some of the world's most well-known brands and retailers. The terms of the transaction include put/call provisions in favour of the vendor and the Company that could result in the Company owning 100% of CosLab.
2023年4月7日，9992,340只被歸類為負債的可轉換債券權證到期，未行使。2023年5月12日，10,281,940份認股權證到期，未行使。
2023年6月5日，不列顛礦業解決方案公司(BMS)，收購了Paragon地球化學實驗室公司100%的權益。平行四邊形“)。Paragon在內華達州經營著一家行業領先的、經充分認可的地球化學實驗室，為採礦業提供礦物分析和地球化學分析。此次收購的部分資金來自一家加拿大私人貸款人提供的新債務安排。
2023年6月6日，Britannia收購了化妝品實驗室有限公司51%的初始股權。CosLab總部設在英格蘭南部的CosLab是一家領先的獨立監管合作夥伴和製造商，為世界上一些最知名的品牌和零售商提供高質量的化妝品。交易條款包括對供應商和公司有利的看跌條款，這可能導致公司擁有CosLab的100%股權。
Subsequent to the end of the quarter, on July 14, 2023, 893,100 brokers' warrants, that were classified as liabilities, expired unexercised, and on July 17, 2023, an additional 50,000 share options expired unexercised.
在本季度結束後，即2023年7月14日，893,100份被歸類為負債的經紀認股權證到期，未行使，2023年7月17日，又有50,000份認股權證到期，未行使。
About Britannia Life Sciences Inc.
不列顛生命科學公司簡介
Britannia Life Sciences Inc. is a global platform offering an integrated suite of services to assist companies along their product development journey. Britannia's services, including product formulations, safety assessments, analytical and microbiological testing, global compliance and consumer evaluations are offered to companies ranging from multinationals to startups particularly in the cosmetics, food and wellness industries. Britannia has garnered significant expertise in the development and regulatory approval of topical and edible cannabis products, including preparation and support for novel food authorizations.
不列顛生命科學公司是一個全球平臺，提供一整套服務，幫助公司在產品開發過程中提供幫助。不列顛的服務，包括產品配方、安全評估、分析和微生物測試、全球合規和消費者評估，提供給從跨國公司到初創公司的各種公司，特別是在化妝品、食品和健康行業。不列顛在局部和可食用大麻產品的開發和監管批准方面積累了大量專業知識，包括準備和支持新的食品授權。
Britannia's head office is located at 120 Adelaide Street West, Suite 2400, Toronto, Ontario, M5H 1T1.
不列顛公司的總部位於安大略省多倫多阿德萊德街西120號，2400號套房，郵編：M5H 1T1。
For further information contact:
如需進一步資訊，請聯繫：
Britannia Life Sciences Inc.
Email: investors@britannia.life
不列顛生命科學公司。
電子郵件：Investors@britannia.life
Forward-Looking Information
前瞻性資訊
This press release may contain certain "forward-looking information" and "forward-looking statements" (collectively, "forward-looking statements") within the meaning of applicable Canadian securities legislation regarding Britannia and its business. Any statement that involves discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions, future events or performance (often but not always using phrases such as "expects", or "does not expect", "is expected" "anticipates" or "does not anticipate", "plans", "budget", "scheduled", "forecasts". "estimates", "believes" or intends" or variations of such words and phrases or stating that certain actions, events or results "may" or "could, "would", "might" or "will" be taken to occur or be achieved) are not statements of historical fact and may be forward-looking statements. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Except as required by law, Britannia assumes no obligation to update the forward-looking statements of beliefs, opinions, projections, or other factors, should they change. The reader is cautioned not to place undue reliance on forward-looking statements.
本新聞稿可能包含某些“前瞻性資訊”和“前瞻性陳述”(統稱為“前瞻性陳述”)，符合加拿大適用的有關不列顛及其業務的證券法的含義。任何涉及關於預測、期望、信念、計劃、預測、目標、假設、未來事件或業績的討論的陳述(經常但不總是使用諸如“預期”或“不預期”、“預期”或“不預期”、“計劃”、“預算”、“預定”、“預測”等措辭。估計“、”相信“或”打算“或此類辭彙和短語的變體，或陳述某些行動、事件或結果”可能“或”可能“、”將“、”可能“或”將“被視為發生或實現)不是歷史事實的陳述，可能是前瞻性陳述。前瞻性陳述必須基於一些估計和假設，這些估計和假設雖然被認為是合理的，但會受到已知和未知的風險、不確定性和其他因素的影響，這些因素可能會導致實際結果和未來事件與此類前瞻性陳述明示或暗示的內容大不相同。除非法律要求，否則不列顛不承擔任何義務更新關於信仰、意見、預測或其他因素的前瞻性陳述，如果它們發生變化。告誡讀者不要過度依賴前瞻性陳述。
For a detailed description of the risks and uncertainties facing the Company and its business and affairs, readers should refer to the Company's filings statement available on SEDAR under the Company's profile at .
有關公司及其業務和事務所面臨的風險和不確定因素的詳細描述，讀者應參考SEDAR上公司簡介下的公司備案聲明。
To view the source version of this press release, please visit
要查看本新聞稿的源版本，請訪問
譯文內容由第三人軟體翻譯。